TNDM stock forecast
Our latest prediction for Tandem Diabetes Care, Inc.'s stock price was made on the Nov. 7, 2018 when the stock price was at 39.56$.
In the short term (2weeks), TNDM's stock price should outperform the market by 0.14%. During that period the price should oscillate between -9.55% and +11.43%.
In the medium term (3months), TNDM's stock price should underperform the market by -0.20%. During that period the price should oscillate between -22.83% and +29.95%.Get email alerts
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
At the moment the company generates 330M USD in revenues.
On its last earning announcement, the company reported a loss of -0.21$ per share.
The book value per share is 0.45$
Three months stock forecastNov. 7, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|